These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30295487)

  • 1. Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects.
    Dalvit C; Vulpetti A
    J Med Chem; 2019 Mar; 62(5):2218-2244. PubMed ID: 30295487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient affinity ranking of fluorinated ligands by
    Rüdisser SH; Goldberg N; Ebert MO; Kovacs H; Gossert AD
    J Biomol NMR; 2020 Nov; 74(10-11):579-594. PubMed ID: 32556806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine NMR functional screening: from purified enzymes to human intact living cells.
    Dalvit C; Veronesi M; Vulpetti A
    J Biomol NMR; 2020 Nov; 74(10-11):613-631. PubMed ID: 32347447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current NMR Techniques for Structure-Based Drug Discovery.
    Sugiki T; Furuita K; Fujiwara T; Kojima C
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29329228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear magnetic resonance of hyperpolarized fluorine for characterization of protein-ligand interactions.
    Lee Y; Zeng H; Ruedisser S; Gossert AD; Hilty C
    J Am Chem Soc; 2012 Oct; 134(42):17448-51. PubMed ID: 23020226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast NMR Methods for Measuring in the Direct and/or Competition Mode the Dissociation Constants of Chemical Fragments Interacting with a Receptor.
    Dalvit C; Parent A; Vallée F; Mathieu M; Rak A
    ChemMedChem; 2019 Jun; 14(11):1115-1127. PubMed ID: 30925009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to
    Urick AK; Calle LP; Espinosa JF; Hu H; Pomerantz WC
    ACS Chem Biol; 2016 Nov; 11(11):3154-3164. PubMed ID: 27627661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process of Fragment-Based Lead Discovery-A Perspective from NMR.
    Ma R; Wang P; Wu J; Ruan K
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NMR screening in fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Yakugaku Zasshi; 2010 Mar; 130(3):325-33. PubMed ID: 20190517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid acquisition of 1H and 19F NMR experiments for direct and competition ligand-based screening.
    Dalvit C; Gossert AD; Coutant J; Piotto M
    Magn Reson Chem; 2011 Apr; 49(4):199-202. PubMed ID: 21387401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of 19F NMR spectroscopy to screen chemical libraries for ligands that bind to proteins.
    Tengel T; Fex T; Emtenas H; Almqvist F; Sethson I; Kihlberg J
    Org Biomol Chem; 2004 Mar; 2(5):725-31. PubMed ID: 14985813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine.
    Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C
    J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of (19)F-NMR in Fragment-Based Drug Discovery.
    Norton RS; Leung EW; Chandrashekaran IR; MacRaild CA
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating protein-ligand binding affinity using high-throughput screening by NMR.
    Shortridge MD; Hage DS; Harbison GS; Powers R
    J Comb Chem; 2008; 10(6):948-58. PubMed ID: 18831571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR screening and hit validation in fragment based drug discovery.
    Campos-Olivas R
    Curr Top Med Chem; 2011; 11(1):43-67. PubMed ID: 20809889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spin-lattice relaxation time in drug discovery and design.
    Figueroa-Villar JD; Tinoco LW
    Curr Top Med Chem; 2009; 9(9):811-23. PubMed ID: 19754396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target immobilization and NMR screening of fragments in early drug discovery.
    Siegal G; Hollander JG
    Curr Top Med Chem; 2009; 9(18):1736-45. PubMed ID: 19929836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weak Intermolecular Hydrogen Bonds with Fluorine: Detection and Implications for Enzymatic/Chemical Reactions, Chemical Properties, and Ligand/Protein Fluorine NMR Screening.
    Dalvit C; Vulpetti A
    Chemistry; 2016 May; 22(22):7592-601. PubMed ID: 27112430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.